Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026)
Stereotaxis' (STXS) quarterly Other Non-Current Liabilities came in at $5.1 million in Q1 2026, down 18.38% year-over-year from $6.3 million in Q1 2025, and up 8.13% quarter-over-quarter from $4.7 million in Q4 2025.
Analysis
Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Other Non-Current Liabilities for 17 consecutive years, with $5.1 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 18.38% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 18.38% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 22.89% from the prior year.
- Other Non-Current Liabilities was $5.1 million for Q1 2026 at Stereotaxis, up from $4.7 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $7.0 million in Q3 2025 and troughed at $43000.0 in Q2 2023.
- A 5-year average of $2.5 million and a median of $202000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 78.71% in 2023 and jumped 14453.49% in 2025, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $51000.0 in 2022, then declined by 15.69% to $43000.0 in 2023, then jumped by 14146.51% to $6.1 million in 2024, then decreased by 22.89% to $4.7 million in 2025, then rose by 8.13% to $5.1 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $5.1 million (Q1 2026), $4.7 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11 Mn |
| Dec 31, 2025 | 4.72 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | 6.26 Mn |
| Dec 31, 2024 | 6.13 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Sep 30, 2022 | 168,000.00 |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 202,000.00 |
| Dec 31, 2021 | 218,000.00 |
| Sep 30, 2021 | 215,861.00 |
| Jun 30, 2021 | 206,596.00 |